hg_240290.1

Basic information about the TSS

---

TSS ID: hg_240290.1 Species: human Chr: chr3		Start: 41240232 End: 41240239 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: U38440 Distance: 20 GeneID: 1499 HGNC/MGI_ID: HGNC:2514 UniProt_ID:

Gene_name: catenin beta 1 Gene_symbol: CTNNB1 Gene_synonyms: armadillo beta-catenin Gene_source: HGNC:2514

TATA-Box annotation

---

Distance to TSS:	488
Nearest PromoterID:	NM_080862
Entrez ID:	92369
Nearest Unigene:	Hs.655112
Nearest Refseq:	NM_080862
Nearest Ensembl:	ENSG00000175093
Gene Name:	catenin beta 1
Gene Alias:	SSB-4|SSB4
Gene Description:	splA/ryanodine receptor domain and SOCS box containing 4
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.731343
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CTNNB1 p2@CTNNB1 p3@CTNNB1 p5@CTNNB1 p8@CTNNB1 p9@CTNNB1
Sample		p1@CTNNB1	p2@CTNNB1	p3@CTNNB1	p5@CTNNB1	p8@CTNNB1	p9@CTNNB1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	227.92	17.14	0.19	3.12	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	246.02	16.19	0.20	0.40	0.00	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	252.51	18.33	0.19	1.16	0.00	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	215.81	13.72	0.00	1.04	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	235.76	14.85	0.22	1.80	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	204.47	13.95	0.19	1.36	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	241.63	16.12	0.00	1.31	0.00	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	225.51	15.02	0.24	0.48	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	211.15	14.11	0.00	2.35	0.00	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	210.40	12.75	0.00	1.16	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	196.46	13.74	0.00	2.02	0.00	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	194.33	15.86	0.00	2.44	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	77.53	13.06	0.00	0.48	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	69.01	15.64	0.30	0.90	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	68.50	15.81	0.00	1.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	64.88	13.58	0.25	0.50	0.00	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	71.20	9.17	0.44	0.44	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	62.43	11.39	0.42	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	71.44	13.33	0.00	0.00	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	57.77	11.28	0.00	0.30	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	70.43	13.90	0.00	0.27	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	73.19	11.57	0.00	0.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	73.81	13.18	0.00	0.65	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	83.48	12.13	0.00	0.73	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	69.40	13.42	0.26	1.29	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	57.29	15.51	0.32	0.95	0.00	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	71.43	10.99	0.00	2.75	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	85.34	14.62	0.00	1.18	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	67.19	12.11	0.00	0.65	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	71.12	14.12	0.18	0.18	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	78.50	16.96	0.21	1.05	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	67.41	14.85	0.59	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	81.88	15.62	0.42	1.48	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	88.24	15.17	0.33	1.32	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	83.02	17.02	0.37	0.93	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	87.76	11.88	0.19	0.77	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	80.93	16.96	0.20	0.82	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	82.61	16.52	0.00	2.22	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	76.98	13.78	0.27	0.81	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	80.66	13.92	0.00	1.20	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	88.22	14.59	0.24	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	86.23	16.69	0.00	1.17	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	84.36	14.76	0.21	0.63	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	73.43	14.34	0.17	0.35	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	93.56	14.66	0.00	0.60	0.20	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	81.43	14.19	0.23	0.93	0.47	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	86.13	14.63	0.00	0.96	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	73.92	11.62	0.00	0.89	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	103.65	19.15	0.48	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	92.81	15.57	0.20	0.81	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	119.28	23.36	0.61	3.28	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	131.20	24.91	0.89	1.11	0.00	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	27.98	0.00	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	119.59	18.10	0.35	1.06	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	116.98	21.54	0.00	1.66	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	104.03	24.33	0.84	3.36	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	126.75	25.26	1.38	5.05	0.00	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	138.72	25.28	0.97	3.57	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	125.58	19.27	1.28	1.28	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	122.27	27.03	0.63	3.46	0.31	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	102.94	17.63	0.00	2.12	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	98.70	14.02	0.00	1.68	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	81.21	11.15	1.59	0.80	0.00	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	112.46	25.48	0.68	2.38	0.34	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	139.72	29.89	0.65	1.95	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	112.17	20.94	0.71	1.42	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	16.16	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	165.85	23.69	0.00	7.90	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	97.02	23.40	0.00	1.95	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	94.71	25.79	0.99	2.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	111.18	19.23	0.00	0.47	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	109.95	35.77	0.33	0.66	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	70.53	23.51	0.00	4.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	89.58	25.38	0.00	1.83	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	372.84	29.78	6.97	0.79	0.48	1.11
Adipocyte - breast, donor2	11327-117E4	202.62	25.03	2.57	1.60	0.64	2.09
Adipocyte - omental, donor1	11473-119C6	300.77	30.15	3.69	1.15	0.64	0.89
Adipocyte - omental, donor2	11474-119C7	257.88	24.67	5.23	2.99	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	152.72	18.42	1.34	1.67	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	219.47	29.35	1.91	0.64	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	87.96	11.00	0.00	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	104.33	13.55	1.35	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	74.90	11.47	0.35	0.70	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	210.44	20.34	3.52	0.39	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	271.28	32.69	5.15	0.77	1.54	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	160.57	22.02	0.84	0.56	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	135.20	26.45	0.59	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	143.65	24.05	0.72	0.56	0.24	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	171.38	28.73	1.29	0.32	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	109.84	21.86	0.00	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	103.50	24.48	0.00	0.56	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	117.28	19.55	0.00	0.83	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	132.87	20.60	2.26	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	111.92	19.96	0.00	0.65	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	77.34	15.22	0.30	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	133.04	11.27	0.22	0.22	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	18.29	1.79	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	22.76	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	174.69	18.35	0.54	0.36	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	80.33	10.04	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	127.58	12.33	0.41	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	320.05	42.68	1.03	1.72	0.34	0.92
Anulus Pulposus Cell, donor2	11463-119B5	206.21	37.23	0.98	0.49	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	221.95	19.77	5.39	2.70	0.00	2.25
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	234.44	27.79	2.60	2.17	0.00	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	252.55	32.10	0.00	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	185.93	20.63	2.39	3.89	0.90	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	197.29	18.97	1.26	2.53	1.26	6.32
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	186.14	25.74	0.66	3.30	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	183.89	26.97	1.95	0.97	1.30	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	197.09	23.79	1.94	2.91	0.49	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	193.60	25.54	1.78	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	212.05	27.49	0.38	2.26	1.13	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	183.60	22.50	0.00	1.45	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	189.32	15.05	3.76	1.25	0.00	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	283.18	27.35	2.64	0.49	0.82	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	182.88	13.65	0.00	4.09	0.00	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	222.57	23.98	1.51	0.60	0.30	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	204.67	28.40	1.07	3.21	0.00	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	181.00	21.16	0.76	1.32	0.38	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	199.66	24.59	1.34	0.80	0.53	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	192.16	14.63	1.95	2.93	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	188.91	23.05	1.33	0.66	0.66	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	180.11	22.81	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	198.25	21.24	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	186.97	19.38	0.86	1.89	1.20	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	180.38	8.39	0.00	4.19	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	207.76	26.21	0.97	1.94	0.00	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	198.83	18.21	0.76	1.52	0.76	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	188.97	24.23	0.00	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	194.38	30.78	3.42	2.28	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	183.21	22.02	1.28	0.64	0.21	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	160.53	18.84	0.77	0.77	0.26	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	205.04	25.34	0.94	3.28	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	207.72	27.65	1.29	1.93	0.64	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	171.94	19.98	2.14	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	208.24	19.89	1.17	2.34	0.00	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	208.34	18.37	1.81	1.51	1.20	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	187.70	21.38	1.19	2.38	1.19	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	211.56	20.34	2.54	2.03	1.02	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	207.83	20.63	2.55	1.53	0.51	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	179.81	15.88	0.64	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	190.74	23.73	3.02	3.88	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	179.93	24.56	0.21	1.27	0.64	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	170.80	22.33	0.87	1.45	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	205.95	31.18	1.89	3.78	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	184.44	20.34	1.02	2.88	0.85	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	159.83	11.58	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	283.08	19.01	2.11	2.11	0.00	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	188.68	20.80	2.14	2.79	0.21	1.93
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	193.74	23.46	1.80	1.20	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	204.11	20.41	2.19	2.92	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	201.38	21.38	2.53	1.61	0.00	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	226.98	30.60	0.00	5.10	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	241.52	20.59	2.54	1.02	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	223.37	26.84	1.65	2.48	0.21	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	182.68	22.64	0.61	0.92	0.31	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	229.92	20.08	1.43	2.39	0.00	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	198.68	20.18	2.88	0.67	0.44	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	140.37	10.68	3.05	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	211.03	15.51	1.11	1.66	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	196.21	21.45	1.85	2.38	0.00	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	162.82	20.72	1.45	0.36	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	193.56	23.83	0.49	0.25	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	74.28	13.18	0.17	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	66.91	4.40	0.84	0.00	0.84	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	443.40	42.88	3.49	1.74	0.70	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	338.43	58.72	1.13	1.78	0.81	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	358.73	50.86	0.75	1.19	0.75	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	96.45	32.34	1.03	0.92	0.23	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	104.48	33.95	1.13	0.63	0.63	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	98.89	34.48	1.14	1.02	0.34	0.00
Basophils, donor1	12241-129G9	282.19	21.18	6.80	0.00	0.78	0.00
Basophils, donor2	12242-129H1	460.74	35.36	14.07	1.80	2.53	0.36
Basophils, donor3	12243-129H2	315.60	15.43	11.02	0.59	0.73	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	59.72	4.31	0.22	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	20.12	0.91	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	265.42	28.69	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	185.16	18.83	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	169.69	19.34	0.42	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	152.91	12.67	0.00	0.92	0.00	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	179.95	18.71	0.00	1.26	0.18	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	202.92	20.71	0.10	0.21	0.21	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	135.08	22.36	0.00	0.93	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	145.18	27.18	0.00	0.00	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	268.89	41.37	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	252.47	11.27	18.60	0.00	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	291.58	17.82	11.88	0.74	1.86	0.56
CD14+ Monocytes, donor3	11381-118B4	233.59	15.15	12.29	0.88	2.41	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	208.32	50.10	0.57	0.28	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	184.99	40.18	2.27	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	200.53	40.44	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	332.17	27.46	7.81	2.89	0.72	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	385.63	23.54	8.45	0.60	1.21	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	330.70	27.48	5.69	1.42	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	393.55	20.42	7.03	3.52	1.67	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	413.74	20.42	6.90	2.48	0.55	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	462.14	22.56	8.68	1.24	0.74	1.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	419.01	19.97	4.11	1.76	0.59	1.76
CD14+ monocytes - treated with BCG, donor2	11870-125B7	361.26	22.26	6.77	0.71	0.18	1.96
CD14+ monocytes - treated with BCG, donor3	11880-125C8	604.14	30.47	7.62	1.96	0.00	2.18
CD14+ monocytes - treated with Candida, donor1	11868-125B5	442.73	18.50	8.43	1.64	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	444.60	20.07	4.75	0.00	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	460.38	22.19	8.87	4.44	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	470.94	26.18	12.05	3.72	1.64	3.27
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	478.32	24.15	11.57	2.99	2.00	2.79
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	602.74	33.10	17.49	2.50	1.46	2.29
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	592.78	24.48	10.98	5.49	1.60	4.12
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	652.60	22.62	14.70	2.04	0.68	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	537.72	20.08	10.04	1.75	0.44	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	374.97	28.24	4.30	2.96	0.81	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	398.29	24.42	7.15	1.74	0.52	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	442.70	36.19	5.05	3.37	0.42	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	473.61	21.13	5.88	4.04	0.55	3.12
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	399.82	16.56	8.45	0.35	1.06	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	440.48	22.81	5.26	0.88	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	396.70	21.80	6.28	2.79	0.70	1.57
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	393.23	18.96	4.83	2.97	0.00	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	588.02	28.24	8.41	3.02	0.86	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	391.47	18.43	4.50	4.09	1.23	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	468.23	16.69	10.20	2.78	0.70	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	486.02	24.36	7.66	1.39	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	139.06	31.17	9.15	0.22	1.31	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	169.09	26.10	11.55	0.23	0.92	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	141.88	24.91	9.31	0.00	1.08	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	147.16	35.82	6.23	0.47	0.47	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	176.39	30.21	6.46	0.52	1.75	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	171.24	39.24	7.58	0.67	0.22	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	122.74	19.90	7.14	0.51	0.26	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	110.22	24.81	8.78	0.88	1.10	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	129.49	25.48	8.21	0.42	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	162.58	58.94	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	164.07	41.36	0.68	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	138.77	37.28	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	179.63	33.05	0.00	0.53	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	177.44	43.42	1.07	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	138.98	37.20	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	153.73	50.20	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	130.51	55.37	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	170.96	46.03	1.64	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	179.91	35.55	2.18	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	201.43	36.35	0.50	0.00	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	84.85	18.18	0.81	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	69.51	14.38	0.40	0.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	189.77	20.08	1.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	313.49	27.53	5.62	0.00	2.25	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	122.87	27.43	0.38	0.00	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	135.29	26.16	0.23	0.00	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	155.32	26.42	1.07	0.00	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	139.01	29.39	0.61	0.61	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	125.96	32.33	0.30	0.61	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	93.42	52.32	0.26	0.51	0.77	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	104.21	45.59	0.45	0.22	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	98.60	54.62	0.29	1.15	0.29	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	176.84	42.67	0.47	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	174.88	52.67	0.00	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	135.15	59.33	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	103.62	35.41	0.00	0.58	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	67.79	32.20	0.34	0.85	0.17	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	78.67	29.02	0.32	0.64	0.16	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	141.21	39.90	0.45	0.90	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	136.61	46.47	1.05	2.10	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	145.19	44.88	0.44	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	100.35	40.06	0.42	1.26	0.00	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	71.47	27.22	0.21	0.00	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	65.15	25.73	0.33	0.00	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	156.63	47.04	0.54	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	182.76	62.17	0.54	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	129.11	48.42	0.00	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	111.81	40.24	0.00	0.37	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	82.31	37.04	0.43	0.87	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	80.70	36.57	0.42	0.00	0.00	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	100.11	32.86	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	127.81	34.66	0.43	0.87	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	133.36	39.66	0.87	0.44	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	164.30	66.81	0.00	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	133.86	55.39	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	135.39	57.23	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	190.53	68.68	0.28	1.38	0.55	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	202.69	70.92	0.49	0.49	0.25	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	172.48	70.84	0.00	1.54	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	162.59	55.87	0.36	0.00	0.36	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	184.20	51.24	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	144.71	26.52	2.62	0.33	0.00	0.65
CD8+ T Cells, donor2	11307-117C2	143.04	24.40	1.50	0.38	0.38	0.75
CD8+ T Cells, donor3	11383-118B6	129.53	27.52	1.01	0.00	0.76	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	181.68	16.29	1.15	0.69	0.69	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	177.81	14.14	2.16	1.68	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	177.83	18.33	1.37	2.19	0.82	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	219.75	30.02	1.50	3.30	0.30	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	219.82	24.96	1.92	2.40	0.24	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	220.34	21.60	1.14	2.27	0.23	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	187.30	23.03	1.30	1.30	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	183.98	24.74	1.58	0.53	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	178.47	23.45	1.88	2.11	0.23	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	175.99	24.15	1.81	1.81	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	165.88	24.11	0.87	2.03	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	179.84	27.98	1.07	2.66	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	239.01	25.83	6.57	0.88	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	231.36	23.68	9.11	1.37	3.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	179.01	21.63	13.43	0.00	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	236.62	24.13	2.16	1.44	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	214.93	23.59	2.01	2.01	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	202.93	21.45	2.36	1.18	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	234.19	20.60	2.54	3.17	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	216.52	26.45	3.08	1.85	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	200.04	22.76	0.64	3.21	0.64	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	180.52	21.04	1.15	0.76	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	182.47	24.83	1.58	0.39	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	190.62	27.99	1.51	4.54	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	198.33	32.92	2.41	2.41	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	223.82	24.48	4.90	2.10	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	254.44	38.07	2.00	4.01	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	164.50	18.28	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	201.09	33.10	0.49	1.98	0.00	1.48
Cardiac Myocyte, donor3	11686-122I3	203.84	20.84	0.21	0.53	0.00	0.32
Chondrocyte - de diff, donor1	11261-116G1	131.39	19.41	0.69	1.39	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	175.56	22.74	1.07	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	261.46	16.50	3.53	1.82	0.68	1.59
Chondrocyte - re diff, donor2	11339-117F7	506.71	45.66	16.11	2.69	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	216.76	14.15	2.83	0.81	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	508.84	60.94	2.18	1.84	0.69	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	317.23	41.68	0.43	1.71	0.43	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	316.56	33.19	2.21	1.59	0.44	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	230.54	33.56	1.56	0.64	0.46	0.18
Corneal Epithelial Cells, donor1	11526-119I5	36.01	3.73	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	71.67	4.55	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	57.26	9.20	0.00	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	196.30	18.49	0.66	0.17	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	188.61	20.82	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	203.59	17.25	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	128.08	14.79	0.43	0.65	0.32	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	152.37	26.65	2.39	0.34	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	155.38	32.64	0.00	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	165.03	38.23	0.97	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	223.14	20.01	2.17	0.33	0.83	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	154.32	17.60	0.59	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	177.03	18.95	1.41	0.57	0.85	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	195.41	16.91	0.79	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	155.33	13.09	1.75	0.58	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	211.75	16.47	2.12	3.76	1.41	1.18
Endothelial Cells - Artery, donor3	11413-118E9	214.93	24.37	1.58	1.05	0.53	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	276.62	19.51	5.10	0.89	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	328.30	20.39	4.26	0.00	1.52	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	503.48	21.14	9.58	1.41	1.69	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	281.68	18.13	3.57	1.19	1.78	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	342.08	11.98	11.45	0.52	1.56	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	213.39	9.36	2.98	1.70	0.99	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	274.08	25.21	3.20	1.60	1.20	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	250.01	15.72	2.62	3.67	1.57	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	388.15	41.62	3.23	1.99	0.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	178.59	20.86	1.09	0.00	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	212.62	24.91	0.49	0.24	0.24	0.49
Endothelial Cells - Vein, donor1	11267-116G7	176.31	19.34	0.00	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	243.08	17.46	1.40	0.70	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	219.18	18.21	1.41	0.31	0.63	0.31
Eosinophils, donor1	12244-129H3	213.46	30.49	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	158.43	24.75	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	149.81	24.97	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	53.75	3.91	0.00	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	29.12	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	471.79	16.27	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	108.79	19.29	0.82	2.05	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	67.12	9.09	0.11	0.99	0.00	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	60.89	11.16	0.00	1.08	0.00	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	181.68	28.14	0.24	0.85	0.00	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	384.03	53.50	0.14	1.36	0.14	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	124.77	17.82	0.32	2.00	0.11	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	216.06	45.32	0.26	1.58	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	133.54	23.59	0.00	1.99	0.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	112.95	19.96	0.00	1.36	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	185.70	14.40	0.76	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	85.96	10.25	0.00	0.79	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	198.23	30.31	0.00	0.00	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	179.70	28.93	2.16	0.51	0.13	0.51
Fibroblast - Cardiac, donor6	11460-119B2	155.08	29.11	0.91	0.91	0.61	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	243.19	20.50	7.77	0.40	1.34	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	292.51	26.75	9.06	1.29	1.29	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	319.32	42.48	1.46	4.39	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	68.96	8.53	0.00	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	207.26	37.31	0.51	0.85	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	116.92	24.18	0.23	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	151.88	29.24	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	106.38	29.38	0.00	1.09	0.00	0.36
Fibroblast - Dermal, donor4	11450-119A1	137.12	40.13	0.23	0.90	0.00	0.34
Fibroblast - Dermal, donor5	11454-119A5	160.32	43.61	0.00	0.70	0.00	0.87
Fibroblast - Dermal, donor6	11458-119A9	166.97	51.16	0.49	0.32	0.16	0.32
Fibroblast - Gingival, donor1	11237-116D4	178.24	36.23	0.21	1.25	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	150.65	32.75	0.00	1.31	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	182.92	43.23	0.13	1.19	0.00	0.53
Fibroblast - Gingival, donor3	11394-118C8	154.41	34.03	0.00	0.10	0.10	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	189.08	30.13	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	224.31	17.44	3.17	1.41	0.88	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	185.67	37.10	0.00	0.47	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	174.85	38.54	0.00	0.68	0.00	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	64.93	14.47	0.00	0.35	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	164.67	38.02	0.29	0.58	0.29	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	185.71	41.18	0.68	0.68	0.27	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	179.35	35.32	0.33	0.77	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	256.21	26.27	2.79	0.88	0.15	0.29
Fibroblast - Lung, donor1	11270-116H1	100.59	29.91	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	186.52	53.72	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	127.89	32.08	0.00	1.69	0.00	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	44.98	8.33	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	8.39	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	9.80	1.12	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	151.02	28.01	0.00	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	15.98	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	29.78	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	218.41	53.92	0.19	0.58	0.00	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	203.71	59.00	0.00	0.76	0.00	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	191.85	44.67	0.31	0.31	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	171.35	30.15	0.00	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	185.21	22.14	0.54	2.16	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	352.56	21.92	8.35	0.81	2.32	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	182.16	25.31	0.66	0.99	0.33	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	61.36	13.61	0.20	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.73	11.36	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	107.54	29.65	0.00	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	367.53	94.06	0.60	1.79	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	185.26	22.74	0.71	0.36	0.00	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	179.54	31.34	0.39	0.39	0.00	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	254.52	66.49	0.00	1.50	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	181.36	36.81	0.22	0.76	0.00	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	380.12	80.98	0.25	1.52	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	180.81	27.89	0.66	0.16	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	298.56	73.99	0.20	0.60	0.40	0.80
Fibroblast - skin normal, donor2	11561-120D4	217.20	38.18	1.41	1.00	0.60	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	460.01	112.43	0.00	2.72	0.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	169.75	31.65	0.33	0.41	0.00	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	197.11	38.81	0.17	1.03	0.00	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	256.83	59.45	0.33	1.64	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	188.12	40.58	0.53	0.75	0.21	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	212.03	48.24	0.17	1.01	0.17	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	73.08	15.21	0.47	1.88	0.16	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	376.72	155.12	0.00	22.16	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	265.82	24.40	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	515.05	26.87	4.51	1.04	1.91	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	544.42	26.54	3.64	1.04	0.78	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	499.53	24.78	7.41	0.77	1.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	388.13	39.04	5.36	3.06	0.77	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	417.94	38.28	3.83	3.83	0.00	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	359.15	39.65	4.85	2.57	4.28	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	360.69	60.39	0.55	1.93	0.55	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	348.20	31.97	2.97	1.83	0.23	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	273.82	28.93	3.17	1.39	1.78	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	322.22	51.81	0.26	1.85	0.00	2.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	409.31	37.18	2.28	2.94	0.98	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	257.82	26.98	6.63	2.21	3.98	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	281.94	34.48	2.40	3.11	2.12	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	288.65	35.46	2.59	1.85	0.49	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	279.10	35.19	1.61	2.95	1.34	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	365.98	33.33	7.81	2.11	3.35	1.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	318.93	39.17	4.01	1.94	2.35	1.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	247.62	27.65	2.64	3.86	1.42	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	383.11	27.61	6.85	2.28	2.97	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	272.30	31.27	3.86	1.87	2.12	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	239.34	29.07	1.97	1.31	0.87	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	385.31	31.91	8.86	2.95	2.07	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	365.60	32.59	3.50	2.38	2.23	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	267.43	23.46	1.79	1.34	1.34	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	415.57	37.91	10.08	4.44	3.83	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	445.65	31.38	10.35	2.37	5.09	1.87
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	540.90	40.35	11.35	1.42	3.01	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	572.10	34.03	37.46	0.62	9.37	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	550.07	35.69	32.11	1.20	7.00	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	443.17	25.34	31.87	2.55	6.09	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	602.67	33.94	26.04	1.41	4.99	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	623.77	41.86	24.71	1.84	4.90	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	417.15	33.83	19.60	1.24	4.75	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	411.14	32.51	18.45	1.96	3.46	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	556.16	30.02	47.36	5.84	8.51	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	405.59	27.11	18.96	3.53	5.51	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	460.36	26.94	33.21	2.34	5.41	1.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	509.13	26.10	32.09	3.57	7.13	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	384.86	28.22	20.21	3.21	4.17	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	494.71	27.10	40.18	2.46	9.19	1.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	572.76	21.99	62.48	2.85	11.07	1.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	542.19	26.15	42.27	2.74	9.73	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	509.10	27.28	36.90	4.29	9.30	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	628.81	19.10	99.02	3.29	18.88	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	491.80	29.74	33.10	2.52	5.61	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	594.59	21.67	66.38	2.04	10.55	2.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	790.71	20.32	105.09	5.62	14.97	1.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	651.65	20.50	67.63	3.37	11.63	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	600.27	19.69	81.74	3.89	13.34	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	861.47	14.37	139.60	5.15	23.58	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	584.02	22.31	49.77	4.06	8.66	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	581.62	22.15	33.34	3.07	5.04	1.97
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	622.82	15.87	63.47	0.00	13.88	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	488.34	27.97	23.61	2.11	4.62	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	418.65	23.00	15.74	2.82	3.63	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	621.17	18.55	38.12	0.00	5.85	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	388.37	48.57	9.16	1.39	5.77	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	234.20	28.50	2.62	0.77	2.16	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	345.54	44.80	5.73	0.82	4.09	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	415.88	30.98	2.19	1.25	0.94	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	376.08	30.80	2.54	0.28	1.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	414.16	36.44	2.77	1.84	1.84	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	425.67	34.65	0.00	4.95	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	417.75	32.11	0.77	3.87	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	497.39	41.72	0.00	8.02	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	429.49	29.56	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	448.18	29.62	0.33	4.88	0.65	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	395.33	29.24	1.24	4.53	0.41	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	313.23	36.65	3.33	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	444.92	27.69	1.68	3.64	0.28	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	434.05	29.74	3.92	3.92	1.31	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	358.18	32.71	2.52	1.68	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	509.55	39.12	2.23	1.91	0.95	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	434.77	35.32	2.72	4.76	1.02	3.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	509.51	50.12	0.00	4.18	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	488.51	36.65	2.29	4.01	0.57	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	381.52	29.60	0.89	2.37	0.89	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	604.81	32.19	5.08	6.78	0.00	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	573.68	36.04	4.97	5.38	0.41	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	464.17	31.30	2.76	6.67	0.69	2.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	447.82	36.88	5.27	5.27	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	429.39	32.68	2.31	2.31	0.77	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	468.42	33.57	1.96	3.59	0.00	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	401.30	21.40	0.67	4.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	440.36	35.83	0.39	3.85	0.77	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	498.10	25.68	1.37	5.14	1.03	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	375.20	39.76	0.00	7.45	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	370.87	30.20	0.00	4.25	0.47	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	404.34	38.62	3.02	3.62	0.00	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	463.40	30.52	1.53	3.05	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	418.78	31.11	0.80	7.18	0.40	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	432.67	31.57	5.92	1.97	0.49	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	442.67	27.15	5.90	4.72	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	402.58	37.92	0.58	5.83	2.33	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	352.42	32.04	2.63	0.88	2.19	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	319.58	19.50	2.54	1.70	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	386.80	23.28	0.60	4.18	0.60	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	384.80	28.14	1.94	3.40	0.49	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	158.64	29.67	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	133.48	24.12	0.83	3.33	0.42	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	157.42	31.48	1.12	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	178.56	26.32	1.27	0.32	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	97.33	19.22	0.00	0.84	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	126.83	27.62	1.28	1.97	0.35	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	160.36	34.94	1.35	1.35	0.00	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	166.30	32.31	0.91	1.82	0.46	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	129.64	29.40	1.75	1.97	0.33	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	155.60	30.73	0.43	1.93	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	175.02	27.34	1.51	0.43	0.00	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	125.91	26.03	1.00	1.00	0.75	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	133.98	26.76	0.86	1.03	0.17	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	136.80	23.39	0.32	1.92	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	102.41	11.19	0.56	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.91	3.46	0.00	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	306.68	18.51	2.64	7.93	0.00	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	66.66	7.41	0.35	0.35	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	42.86	3.63	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	160.50	18.71	1.22	1.05	0.52	0.52
Hepatocyte, donor1	11523-119I2	179.17	26.63	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	201.46	49.56	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	185.29	28.84	0.61	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	84.20	16.32	0.65	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	106.09	4.19	29.19	0.70	4.72	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	213.22	28.26	0.69	0.55	0.55	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	60.49	35.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	20.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	55.38	26.30	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	15.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	30.75	0.00	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	9.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	76.34	47.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	73.36	31.68	0.00	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	25.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	82.06	47.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	51.00	23.28	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	62.86	15.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	64.25	23.93	0.00	0.63	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	47.95	26.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	46.51	41.99	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	48.30	27.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	47.79	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	68.45	31.78	0.00	2.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	68.43	39.04	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	69.12	26.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	48.01	23.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	40.12	24.07	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	53.51	29.02	0.00	0.91	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	53.81	27.98	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	63.52	40.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	65.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	51.65	18.49	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	47.39	21.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	56.41	29.99	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	73.00	43.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	44.76	20.68	0.00	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	54.44	28.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	15.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	53.54	34.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	28.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	16.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	30.52	17.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	13.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	24.39	0.00	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	34.14	23.47	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	31.87	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	42.74	19.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	42.34	17.49	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	9.08	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	18.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	16.92	14.80	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	507.22	17.79	4.73	1.71	0.82	1.22
Keratinocyte - epidermal, donor2	11349-117G8	155.19	11.71	0.00	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	182.59	27.64	0.19	0.66	0.00	0.47
Keratinocyte - oral, donor1	11251-116E9	504.13	32.35	0.91	1.48	0.57	1.14
Keratocytes, donor1	11527-119I6	70.14	10.66	0.00	0.00	0.00	1.03
Keratocytes, donor2	11607-120I5	36.33	8.20	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	128.83	19.17	0.00	0.79	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	879.17	48.35	10.99	0.00	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	225.46	28.05	1.08	3.24	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	305.86	36.10	0.23	1.04	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	239.36	19.88	2.12	0.30	1.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	368.06	20.28	4.98	1.30	1.42	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	179.72	12.84	1.40	0.84	1.12	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	310.57	17.63	3.15	1.89	0.94	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	274.23	17.21	3.76	1.61	0.00	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	192.88	12.29	1.58	0.95	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	210.78	12.08	1.51	1.29	0.54	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	311.49	19.29	2.87	2.46	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	134.75	4.30	2.53	0.51	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	227.03	12.53	1.55	2.25	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	209.63	12.26	1.58	0.79	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	201.25	7.17	3.10	1.16	0.39	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	159.41	9.26	1.48	0.74	0.56	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	282.92	8.36	3.48	2.09	0.35	2.79
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	196.78	12.40	3.34	0.72	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	220.17	12.77	1.37	0.96	0.69	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	295.33	8.62	2.77	0.62	0.62	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	129.06	7.79	1.25	0.62	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	223.25	12.26	0.91	0.73	0.91	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	279.09	11.19	2.30	1.32	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	148.78	6.44	1.76	0.59	0.29	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	180.22	10.95	1.49	1.24	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	265.27	11.15	1.94	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	174.77	5.39	3.23	0.81	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	273.24	14.53	2.57	2.12	0.45	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	270.61	13.48	2.59	0.52	2.07	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	200.18	6.91	4.61	0.21	1.47	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	250.67	11.28	3.31	2.26	0.60	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	239.38	8.25	2.75	1.38	1.38	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	179.68	7.71	1.88	0.94	0.94	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	207.92	10.07	2.01	0.95	0.74	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	270.39	12.60	2.42	0.48	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	161.43	5.62	1.32	0.99	0.66	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	211.73	11.03	2.73	1.86	0.87	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	371.69	19.25	5.18	2.96	1.85	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	180.62	5.44	2.72	0.25	0.49	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	208.99	9.62	2.20	1.10	0.82	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	289.80	9.33	3.86	2.89	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	236.46	9.13	2.13	0.61	1.52	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	315.20	14.14	3.64	1.68	0.70	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	297.96	14.58	2.13	2.13	0.36	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	120.71	4.85	1.45	0.97	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	146.89	8.71	1.56	0.78	0.78	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	270.73	13.25	3.22	0.72	0.36	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	181.96	5.55	4.90	1.31	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	138.66	6.83	1.88	1.18	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	352.20	16.21	6.68	0.99	1.24	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	126.53	4.61	1.02	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	187.67	8.35	2.09	1.19	1.49	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	190.34	15.86	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	164.17	6.90	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	132.12	12.62	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	179.41	19.46	0.00	0.42	0.00	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	130.11	9.85	0.00	2.11	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	129.82	7.47	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	143.76	12.88	0.52	2.58	0.00	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	132.03	11.89	0.00	1.19	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	153.13	14.02	0.00	0.68	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	167.81	14.54	0.00	1.45	0.00	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	151.71	12.60	0.00	3.15	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	189.54	13.14	0.14	0.14	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	174.60	22.08	0.00	2.57	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	140.08	13.76	0.00	1.06	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	141.26	11.33	1.33	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	169.12	20.88	0.51	1.53	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	159.55	16.01	0.00	0.80	0.00	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	166.08	14.36	0.19	0.94	0.00	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	189.59	17.79	0.00	1.84	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	152.48	17.12	0.00	3.26	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	159.31	16.87	0.21	1.46	0.00	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	170.68	16.54	0.28	1.96	0.00	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	162.79	14.42	1.03	1.03	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	169.54	18.58	0.29	1.45	0.00	3.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	158.73	17.94	0.60	1.20	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	161.00	8.85	0.55	1.66	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	180.63	17.32	0.35	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	178.12	15.86	0.00	1.48	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	126.64	13.82	0.00	1.15	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	176.91	21.11	0.00	1.54	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	178.33	13.59	0.00	1.70	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	173.94	15.59	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	176.23	14.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	173.07	15.08	0.72	2.87	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	148.63	13.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	180.59	18.95	0.00	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	180.05	13.35	0.00	1.29	0.00	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	145.57	13.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	175.92	15.33	0.00	0.67	0.00	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	180.99	15.08	0.00	1.81	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	124.42	12.80	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	175.64	16.50	0.00	2.06	0.00	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	194.84	20.93	1.07	2.68	0.00	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	151.51	7.41	0.00	1.35	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	179.65	16.30	0.00	1.11	0.00	2.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	181.42	10.47	0.00	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	119.52	10.58	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	174.07	15.61	0.00	1.20	0.00	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	188.99	25.44	0.00	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	179.36	14.56	0.00	3.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	182.51	21.21	0.00	0.49	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	189.13	17.88	0.00	1.88	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	173.98	13.58	0.00	1.51	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	191.52	15.77	0.00	1.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	197.93	27.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	182.15	18.26	0.00	3.56	0.00	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	210.76	23.85	0.00	2.74	0.00	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	184.07	16.49	0.00	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	186.29	20.24	0.00	1.04	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	197.78	18.38	0.00	1.75	0.44	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	191.77	19.57	0.00	2.24	0.00	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	188.14	22.52	0.44	0.88	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	178.59	17.36	0.39	1.54	0.00	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	200.01	23.29	0.00	0.51	0.00	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	191.77	17.78	0.00	0.48	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	178.50	19.88	0.00	1.59	0.00	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	205.98	19.44	0.00	2.43	0.61	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	152.87	14.53	0.00	0.69	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	194.94	18.62	0.00	1.90	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	203.47	19.11	0.00	1.55	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	188.65	16.33	0.60	1.81	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	178.73	14.89	0.32	1.58	0.32	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	208.97	17.06	0.00	0.53	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	187.34	14.37	0.00	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	179.98	14.91	0.00	2.06	0.00	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	212.91	12.73	0.00	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	190.11	14.19	0.00	3.97	0.00	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	179.72	18.72	0.00	1.66	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	230.21	27.41	0.00	1.57	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	163.68	14.20	0.00	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	175.17	14.40	0.00	0.93	0.00	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	172.61	11.37	0.00	1.34	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	187.12	16.04	0.00	2.14	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	183.86	15.36	0.00	1.21	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	181.72	13.77	0.00	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	191.16	10.67	0.89	0.89	0.89	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	188.06	16.53	0.00	1.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	179.45	14.57	0.00	1.53	0.00	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	174.00	15.87	0.55	1.09	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	177.73	10.25	0.45	0.89	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	222.00	15.60	0.00	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	170.42	13.93	0.00	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	197.47	8.31	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	141.31	28.03	0.46	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	111.39	16.70	0.00	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	116.92	23.73	0.13	0.39	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	420.04	23.36	2.12	0.53	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	515.92	29.63	2.38	1.27	0.32	1.27
Mallassez-derived cells, donor3	11930-125I4	545.53	27.52	5.28	2.50	1.25	2.08
Mammary Epithelial Cell, donor1	11273-116H4	312.78	16.24	0.50	1.30	0.00	0.60
Mammary Epithelial Cell, donor2	11350-117G9	335.88	26.64	0.87	1.45	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	295.32	19.70	1.25	0.50	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	513.88	23.05	25.76	0.00	2.71	0.00
Mast cell, donor1	11563-120D6	299.98	23.03	5.41	0.32	0.65	0.43
Mast cell, donor2	11565-120D8	134.03	32.39	1.19	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	159.39	39.85	1.35	0.23	0.45	0.45
Mast cell, donor4	11567-120E1	113.64	31.20	2.30	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	286.33	46.58	11.98	1.00	1.89	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	208.37	26.85	9.34	0.58	2.33	0.00
Mast cell, expanded, donor5	11939-126A4	267.42	48.87	2.64	0.69	1.03	0.46
Mast cell, expanded, donor8	11941-126A6	245.86	38.83	9.71	0.50	1.34	0.67
Melanocyte - dark, donor1	11502-119F8	384.16	26.76	6.07	1.19	3.18	0.80
Melanocyte - dark, donor2	11582-120F7	228.76	26.99	4.50	1.73	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	951.80	20.57	68.09	1.96	10.79	1.67
Melanocyte - light, donor1	11274-116H5	356.60	12.93	21.16	0.24	3.29	1.18
Melanocyte - light, donor2	11351-117H1	595.79	17.74	23.20	1.36	4.09	0.00
Melanocyte - light, donor3	11423-118G1	214.20	16.48	2.60	1.73	0.87	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	645.06	23.22	23.74	5.21	5.10	1.87
Melanocyte, donor2 (MC+2)	12739-135I3	665.63	24.20	80.41	4.84	8.07	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	627.32	33.48	23.04	3.21	3.21	1.61
Meningeal Cells, donor1	11493-119E8	199.86	35.11	0.99	0.50	0.62	0.00
Meningeal Cells, donor2	11573-120E7	194.11	32.57	3.08	0.88	0.44	0.44
Meningeal Cells, donor3	11654-122E7	305.55	61.94	2.12	1.30	0.98	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	217.00	41.92	0.29	0.29	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	199.05	19.52	2.62	0.50	0.20	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	17.08	2.63	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	22.24	5.23	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	127.73	30.86	1.44	2.15	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	171.32	30.71	0.85	0.64	0.21	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	157.83	26.64	0.00	1.51	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	71.20	11.87	0.00	0.00	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	56.99	10.96	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	38.67	9.21	0.20	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	288.37	21.19	1.52	0.83	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	38.29	5.20	0.00	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	188.94	28.81	1.05	0.13	0.53	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	37.69	5.64	0.59	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	4.67	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	49.31	8.97	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	187.86	37.57	0.71	1.06	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	156.36	25.02	0.31	0.00	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	158.93	29.75	0.73	2.90	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	212.41	15.91	0.80	1.06	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	188.18	15.51	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	177.27	19.73	0.36	0.72	0.00	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	136.38	25.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	142.59	32.26	0.99	0.99	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	110.13	23.56	0.00	0.00	1.18	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	183.23	20.74	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	129.87	26.97	0.62	0.31	1.24	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	103.51	18.46	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	157.49	30.11	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	134.64	29.03	1.25	1.25	0.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	120.09	21.88	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	253.06	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	129.25	28.86	0.61	1.02	0.20	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	115.23	24.15	1.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	350.61	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	131.86	38.05	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	113.98	17.10	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	178.96	17.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	129.88	28.01	1.27	0.85	0.21	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	105.89	14.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	862.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	123.40	27.72	0.89	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	144.19	21.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	509.24	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	155.81	21.83	2.26	1.51	0.25	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	99.11	16.16	1.19	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	228.34	15.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	172.68	20.72	3.45	1.15	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	121.58	21.66	0.63	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	164.08	17.12	2.24	0.82	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	172.70	20.60	2.79	2.36	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	116.26	18.67	0.67	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	515.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	199.52	18.62	2.41	1.75	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	131.81	21.80	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	293.29	16.57	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	213.90	17.39	3.81	0.27	0.82	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	161.45	19.70	0.88	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	255.14	11.99	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	211.92	22.11	4.32	1.44	1.44	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	172.90	16.01	3.60	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	255.05	10.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	255.29	21.02	3.50	1.00	0.50	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	296.42	80.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	216.08	12.23	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	289.47	24.09	4.38	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	227.35	15.45	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	257.44	12.81	1.92	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	306.43	25.54	4.46	2.73	0.99	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	199.72	13.92	2.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	324.85	15.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	215.38	25.64	3.76	1.37	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	214.43	14.00	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	186.78	15.62	1.42	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	233.42	26.65	4.49	0.56	1.12	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	202.41	21.61	0.83	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	181.23	15.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	192.46	20.51	1.81	1.81	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	180.73	30.47	2.50	0.42	1.25	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	216.56	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	165.32	25.86	2.77	0.00	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	180.98	27.89	2.28	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	91.75	14.51	0.97	0.28	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	146.16	18.66	1.81	0.52	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	160.01	14.59	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	102.90	10.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	120.10	15.21	0.80	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	163.13	28.74	1.80	0.30	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	68.93	14.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	130.91	19.75	0.64	0.96	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	169.61	22.33	1.77	0.66	0.00	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	93.66	8.34	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	113.07	17.90	1.14	0.85	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	176.73	21.63	2.21	0.74	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	96.45	14.34	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	120.26	25.87	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	132.63	32.87	0.86	0.86	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	107.57	25.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	112.56	25.01	0.30	0.30	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	109.24	37.67	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	153.27	37.43	0.00	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	150.16	34.50	0.99	1.97	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	111.51	29.45	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	179.10	41.71	1.98	0.59	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	149.94	26.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	111.91	22.91	0.38	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	94.02	27.43	1.07	1.07	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	190.12	33.48	1.02	0.34	0.11	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	138.50	24.31	0.74	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	139.97	37.74	0.73	1.10	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	143.11	26.45	0.00	4.67	1.56	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	92.46	13.90	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	85.01	15.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	151.49	36.36	1.01	1.01	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	67.46	13.07	0.84	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	32.69	4.09	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.72	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	17.82	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	3.02	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	125.62	5.71	28.55	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	110.92	13.05	45.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	232.87	19.01	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	163.14	0.00	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	205.74	26.28	0.00	0.65	0.43	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	149.47	19.34	0.00	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	87.44	22.69	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	81.39	12.10	0.00	1.67	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	119.41	30.80	0.57	1.90	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	256.93	49.47	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	61.87	19.72	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	84.53	18.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	79.94	17.58	0.84	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	99.95	23.48	0.23	0.46	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	95.66	26.75	0.27	0.81	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	150.32	38.89	0.42	0.21	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	133.62	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	85.37	19.36	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	117.74	24.36	0.81	1.08	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	88.41	19.49	0.68	0.68	0.23	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	108.43	20.74	0.65	0.49	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	132.13	30.98	1.28	0.36	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	98.66	19.10	0.00	2.12	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	81.04	16.81	0.00	0.60	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	97.47	21.99	1.64	1.64	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	89.44	15.77	0.33	0.81	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	147.63	23.81	1.76	0.35	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	76.65	14.77	0.00	2.11	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	97.92	17.01	0.46	0.92	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	108.94	23.46	2.25	0.64	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	92.77	23.11	1.38	1.38	1.38	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	121.37	27.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	151.49	24.06	2.01	0.67	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	109.24	13.55	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	102.54	18.28	0.00	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	115.90	15.45	3.00	0.43	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	45.14	9.03	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	118.96	23.66	1.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	168.62	18.49	0.00	0.45	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	90.87	15.87	1.59	0.79	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	84.51	18.57	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	151.73	20.05	0.76	0.38	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	84.40	9.12	0.33	0.98	0.65	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	127.25	13.07	1.74	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	196.74	24.88	1.81	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	76.73	15.87	3.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	81.11	12.63	0.00	1.33	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	131.95	16.37	0.00	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	86.14	15.31	0.38	0.77	0.38	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	275.23	31.15	2.12	2.42	0.60	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	181.46	22.10	1.33	0.44	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	98.26	11.52	0.00	0.68	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	158.40	15.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	151.81	18.29	0.61	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	116.77	15.11	1.26	0.31	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	134.98	16.65	1.21	1.51	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	151.90	12.66	1.58	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	132.64	23.81	3.40	6.80	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	131.51	20.23	5.06	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	208.70	20.87	1.61	0.75	0.37	0.87
Myoblast, donor2	11322-117D8	188.34	35.86	0.58	2.30	0.19	1.15
Myoblast, donor3	11398-118D3	267.21	27.24	3.36	0.17	1.18	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	80.41	15.76	0.58	0.15	0.44	0.29
Natural Killer Cells, donor1	11230-116C6	203.58	30.14	5.54	0.00	0.62	0.62
Natural Killer Cells, donor2	11311-117C6	137.81	26.84	0.90	0.90	0.60	0.90
Natural Killer Cells, donor3	11387-118C1	147.80	26.14	3.31	0.55	0.18	0.00
Neural stem cells, donor1	11275-116H6	542.23	82.39	1.45	0.36	1.09	0.73
Neural stem cells, donor2	11352-117H2	439.05	65.47	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	282.20	52.34	0.00	3.41	1.14	0.00
Neurons, donor2	11574-120E8	250.11	51.96	0.44	0.22	0.22	0.66
Neurons, donor3	11655-122E8	184.17	27.13	0.00	3.29	0.00	1.64
Neutrophils, donor1	11233-116C9	106.72	26.91	2.78	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	75.37	14.49	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	175.92	36.04	1.22	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	291.26	38.35	0.95	1.90	0.36	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	181.69	27.68	1.30	1.95	0.98	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	150.82	22.26	0.80	0.80	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	77.77	19.13	0.00	0.83	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	103.64	20.12	0.43	2.46	0.00	1.88
Olfactory epithelial cells, donor3	11935-125I9	89.78	19.52	0.11	0.34	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	116.29	30.68	0.00	0.19	0.00	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	355.07	27.68	2.41	1.81	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	212.06	16.38	2.13	0.21	0.64	0.21
Osteoblast - differentiated, donor2	11353-117H3	243.48	8.00	6.86	0.00	1.14	2.29
Osteoblast - differentiated, donor3	11425-118G3	64.55	13.03	0.00	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	151.27	30.10	1.17	0.39	0.00	0.39
Osteoblast, donor2	11354-117H4	268.29	44.25	0.70	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	204.92	28.79	0.00	0.53	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	170.41	33.69	0.25	1.35	0.08	0.51
Pericytes, donor1	11491-119E6	30.26	3.56	0.11	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	43.46	4.30	0.23	0.91	0.45	0.00
Pericytes, donor3	11652-122E5	52.90	7.32	0.20	0.61	0.00	0.00
Perineurial Cells, donor1	11499-119F5	197.90	28.93	0.79	0.57	0.34	0.45
Perineurial Cells, donor2	11579-120F4	264.81	36.62	2.30	0.46	0.64	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	248.94	45.58	8.61	0.32	0.96	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	213.03	26.45	7.84	0.49	0.49	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	208.10	23.68	4.92	0.52	0.39	0.52
Placental Epithelial Cells, donor1	11278-116H9	178.42	21.52	0.24	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	185.18	15.52	0.00	0.00	0.00	3.33
Placental Epithelial Cells, donor3	11427-118G5	162.95	15.31	0.39	0.98	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	100.32	12.97	2.85	0.95	0.63	0.95
Preadipocyte - breast, donor1	11467-119B9	205.22	25.32	1.31	0.38	1.13	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	749.88	77.53	13.84	1.44	2.87	1.44
Preadipocyte - breast, donor2	11328-117E5	207.59	32.65	2.48	2.25	0.23	0.90
Preadipocyte - omental, donor1	11468-119C1	175.72	26.96	0.75	0.43	0.11	0.64
Preadipocyte - omental, donor2	11329-117E6	313.39	32.30	3.93	0.44	1.75	0.44
Preadipocyte - omental, donor3	11403-118D8	176.77	24.07	1.43	0.86	0.14	1.15
Preadipocyte - perirenal, donor1	11469-119C2	141.73	14.76	0.98	2.95	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	136.67	28.56	0.31	0.00	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	176.90	46.39	0.35	2.12	0.00	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	128.22	27.25	0.85	1.53	0.34	0.68
Preadipocyte - visceral, donor1	11280-116I2	171.11	45.36	0.37	0.37	0.09	0.28
Preadipocyte - visceral, donor2	11357-117H7	163.82	40.50	1.38	2.76	0.00	1.84
Preadipocyte - visceral, donor3	11429-118G7	117.66	29.99	0.00	2.19	0.21	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	115.25	3.62	26.70	0.91	4.07	0.30
Prostate Epithelial Cells, donor2	11331-117E8	505.23	13.14	12.19	6.09	1.90	3.25
Prostate Epithelial Cells, donor3	11404-118D9	143.79	9.55	0.06	0.55	0.06	0.86
Prostate Stromal Cells, donor1	11254-116F3	159.35	26.77	0.00	0.23	0.23	0.80
Prostate Stromal Cells, donor2	11332-117E9	147.74	26.54	0.36	1.08	0.00	0.90
Prostate Stromal Cells, donor3	11405-118E1	111.89	19.71	0.10	1.25	0.00	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	46.72	6.93	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	276.35	32.78	0.14	1.11	0.07	0.21
Renal Epithelial Cells, donor1	11517-119H5	23.33	5.07	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	40.55	9.96	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	289.54	43.93	0.11	1.27	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	51.06	6.13	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	88.14	13.07	0.54	0.13	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	292.83	41.74	1.78	1.78	0.00	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	44.58	2.66	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	71.31	8.36	0.22	0.00	0.44	0.22
Renal Mesangial Cells, donor2	11598-120H5	71.48	11.91	0.00	1.25	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	24.69	3.05	0.00	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	108.44	16.91	0.00	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	41.33	7.17	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	54.58	10.99	0.00	0.77	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	229.46	32.41	0.00	1.30	0.00	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	108.58	13.08	0.00	0.28	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	31.90	2.06	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	170.87	19.82	0.00	0.50	0.00	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	286.65	24.46	3.47	0.94	0.80	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	936.29	33.95	56.28	0.00	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	622.47	26.42	162.91	6.05	15.41	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	716.95	30.16	81.79	0.58	5.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	717.61	63.58	100.12	1.17	16.64	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	590.97	48.96	57.40	2.38	8.04	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	895.88	56.10	96.48	1.67	15.84	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	755.42	71.45	96.88	3.97	17.61	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	658.83	55.59	65.85	4.55	10.72	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	744.71	52.93	87.60	5.08	13.87	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	504.10	47.37	54.49	1.92	11.91	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	622.49	48.41	72.46	3.78	11.19	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	829.29	59.85	79.74	0.90	12.18	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	579.71	57.38	59.53	3.44	10.76	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	619.42	50.65	66.21	3.11	10.30	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	633.50	44.03	74.13	2.66	15.49	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	466.85	52.00	46.26	1.72	11.66	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	523.95	42.02	60.28	1.49	11.27	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	916.61	63.51	98.46	1.50	16.72	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	491.28	46.31	55.74	0.80	14.07	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	618.70	50.03	55.58	2.92	8.96	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	657.85	49.27	67.41	1.53	12.41	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	542.19	51.90	60.45	1.60	11.96	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	625.64	45.97	68.39	8.13	6.73	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	603.78	42.55	58.62	2.22	8.03	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	522.38	49.41	49.41	2.01	9.66	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	566.56	43.78	57.15	3.56	8.46	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	676.97	42.71	61.92	2.96	9.13	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	618.22	71.23	59.20	3.77	16.75	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	584.13	48.41	56.15	2.98	9.72	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	711.36	49.58	85.12	2.34	13.10	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	547.42	60.76	54.33	2.90	11.82	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	667.61	48.89	72.56	5.75	8.41	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	563.36	36.76	50.97	1.67	7.73	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	558.12	55.58	55.18	1.75	8.08	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	559.59	44.79	59.09	0.34	10.56	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	558.14	42.03	53.98	1.74	9.06	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	499.82	68.26	56.74	3.95	10.32	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	526.45	43.48	39.64	0.82	8.09	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	513.36	42.19	58.44	3.61	10.34	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	462.38	55.90	51.30	1.70	10.40	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	600.26	43.35	59.63	3.26	9.47	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	484.59	40.78	46.91	1.87	10.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	560.67	31.80	47.56	1.11	8.02	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	651.69	55.48	55.48	3.10	10.48	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	628.81	45.95	65.10	0.81	12.29	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	605.07	49.54	61.50	3.67	10.83	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	712.35	35.63	45.07	4.54	9.43	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	612.28	24.18	36.27	0.60	10.28	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	664.07	45.28	86.77	4.41	13.34	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	992.81	40.03	81.95	1.89	12.66	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	763.58	36.51	63.28	4.26	7.91	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	663.68	49.13	90.42	4.22	15.97	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	678.11	24.65	51.12	4.30	5.43	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	712.91	33.85	49.72	5.39	12.58	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	847.07	34.71	74.27	3.66	10.51	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	659.54	25.40	48.45	2.56	4.91	5.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	630.43	32.45	55.29	0.60	9.01	0.60
Schwann Cells, donor1	11498-119F4	56.61	9.78	0.56	0.00	0.38	0.00
Schwann Cells, donor2	11578-120F3	241.57	51.04	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	359.73	41.63	3.29	2.85	0.88	0.66
Sebocyte, donor1	11220-116B5	479.30	21.36	0.55	0.55	0.00	1.10
Sebocyte, donor2	11301-117B5	303.31	17.00	0.92	1.84	0.00	0.46
Sebocyte, donor3	11378-118B1	142.01	13.19	0.21	0.41	0.00	0.41
Sertoli Cells, donor1	11255-116F4	167.32	31.48	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	138.39	14.12	0.00	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	231.29	26.22	0.62	0.44	0.35	0.62
Skeletal Muscle Cells, donor2	11358-117H8	70.12	11.57	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	151.32	35.11	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	165.89	38.02	0.47	1.26	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	171.68	38.50	0.74	1.04	0.59	0.59
Skeletal Muscle Cells, donor6	11459-119B1	202.23	41.71	0.92	2.00	0.00	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	241.55	45.61	0.63	0.50	0.13	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	198.48	40.95	0.29	1.14	0.29	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	244.25	45.64	0.60	1.29	0.69	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	411.40	28.56	3.62	1.10	1.18	0.76
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	131.00	15.92	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	142.00	30.13	1.10	0.83	0.14	0.28
Skin - palm, donor1	10286-104F7	392.17	18.80	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	295.38	13.98	0.86	2.31	0.14	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	1001.10	47.44	1.64	6.54	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	270.56	14.93	0.91	1.69	0.00	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	426.75	13.62	6.39	1.11	0.70	1.39
Small Airway Epithelial Cells, donor2	11334-117F2	274.56	8.86	1.27	0.84	0.42	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	726.74	27.07	2.75	1.69	1.06	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	187.83	11.02	0.52	1.27	0.22	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	67.58	13.58	0.00	1.54	0.00	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	181.64	33.57	0.44	0.67	0.22	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	146.37	22.93	1.76	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	191.38	38.89	0.44	0.22	0.66	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	155.54	15.36	1.18	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	148.33	30.13	0.00	0.00	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	198.15	27.02	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	220.51	25.95	1.06	0.27	0.27	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	121.91	25.05	1.55	1.55	0.22	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	197.81	30.22	0.13	0.38	0.13	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	278.05	29.30	3.58	0.98	1.30	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	233.60	29.83	1.18	0.59	0.59	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	167.14	24.06	0.00	0.57	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	15.29	2.93	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	122.99	21.31	0.91	0.61	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	114.92	26.27	0.25	0.00	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	24.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	136.38	28.13	0.00	0.00	0.00	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	190.54	29.64	0.15	0.15	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	155.19	24.54	0.43	0.86	0.22	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	168.35	29.07	0.21	0.52	0.10	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	119.26	18.72	0.62	0.31	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	104.55	15.09	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	161.98	20.92	0.60	0.90	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	24.58	3.07	0.00	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	189.26	30.63	0.24	0.79	0.00	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	138.18	24.46	0.10	0.70	0.00	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	179.31	18.66	1.37	1.14	0.23	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	136.46	18.72	1.81	1.21	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	225.19	41.33	0.53	0.00	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	150.47	28.50	0.13	0.40	0.13	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	140.25	24.04	0.00	1.00	0.13	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	100.70	19.02	0.25	0.25	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	176.56	33.17	0.45	0.30	0.00	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	101.27	28.51	0.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	971.75	283.00	1.29	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	115.34	28.83	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	106.53	19.19	0.00	1.01	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	136.95	24.76	0.31	1.25	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.07	5.01	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	192.52	35.82	0.08	0.33	0.08	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	153.23	31.30	1.87	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	223.94	24.18	1.30	0.00	0.58	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	162.15	24.48	0.25	0.25	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	121.47	27.08	0.38	0.56	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	229.46	37.45	0.70	0.56	0.42	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	214.16	24.89	0.50	0.67	0.17	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.29	2.86	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	203.80	23.73	1.47	0.73	0.49	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	157.09	25.85	0.66	1.77	0.00	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	100.94	26.92	0.00	0.88	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	108.84	18.08	0.19	0.39	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	104.19	18.51	0.53	1.06	0.00	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	87.04	28.64	0.37	0.37	0.37	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	150.20	25.87	0.00	0.36	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	156.71	24.98	0.00	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	129.98	31.90	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	111.99	20.06	0.25	1.52	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	113.81	25.56	0.00	0.80	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	84.86	13.38	0.00	1.67	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	104.05	27.96	0.00	0.92	0.00	0.92
Synoviocyte, donor1	11291-117A4	190.71	24.07	0.00	1.01	0.17	0.67
Synoviocyte, donor2	11368-117I9	180.03	22.80	1.84	1.17	0.00	0.67
Synoviocyte, donor3	11440-118H9	90.70	16.53	0.67	0.45	0.22	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	58.60	12.15	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	31.71	3.96	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	42.84	5.79	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	220.64	19.35	0.43	0.50	0.14	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	198.31	17.40	0.77	1.55	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	175.23	13.17	0.57	0.57	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	287.02	24.24	4.06	1.11	0.62	0.49
Urethra, donor2	10319-105A4	226.60	16.19	3.60	0.00	1.80	3.60
Urothelial Cells, donor1	11520-119H8	138.68	7.70	0.00	0.00	0.27	0.80
Urothelial Cells, donor2	11600-120H7	117.37	6.81	0.80	0.80	0.80	0.40
Urothelial Cells, donor3	11681-122H7	63.03	5.04	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	481.01	26.97	5.80	1.56	1.56	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	145.03	39.15	4.45	2.67	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	148.68	58.61	4.29	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	91.04	30.12	0.00	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	108.81	33.40	1.03	0.00	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	133.64	37.77	0.00	1.16	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	148.90	43.73	6.25	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	160.61	42.22	1.84	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	85.81	23.74	1.83	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	169.13	28.87	0.12	1.60	0.12	0.25
Wilms' tumor cell line:HFWT	10597-108E3	199.77	23.76	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	165.91	29.61	0.56	0.84	0.28	0.84
achilles tendon, donor2	10292-104G4	247.98	24.80	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	163.17	22.18	0.25	0.76	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	120.96	18.81	0.00	0.23	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	95.20	12.11	0.00	0.36	0.24	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	78.91	13.33	0.00	0.27	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	235.83	43.01	6.75	1.12	0.56	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	130.70	19.88	0.63	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	82.75	12.79	0.54	0.27	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	141.45	31.29	3.53	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	122.10	33.08	0.41	2.45	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	88.14	22.91	0.00	0.39	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	57.41	22.08	0.18	0.55	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	152.12	42.91	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	173.82	35.32	0.70	1.16	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	89.84	38.32	0.52	0.00	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	85.92	35.95	0.00	1.17	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	124.56	20.91	0.93	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	107.75	24.68	0.00	1.23	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	193.38	19.95	0.31	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	267.97	17.92	2.13	0.43	2.13	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	287.83	23.96	1.21	0.30	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	312.20	25.27	3.37	0.96	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	86.20	20.05	0.22	0.89	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	173.11	24.02	1.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	141.22	44.60	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	168.74	29.76	0.75	0.00	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	161.37	26.60	3.05	0.00	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	97.47	18.74	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	138.94	36.03	0.00	0.00	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	213.29	29.63	1.09	1.09	0.47	0.16
adipose, donor1	10184-103D4	360.06	52.78	3.52	8.21	0.59	7.04
adipose, donor2	10185-103D5	242.91	24.33	0.81	1.22	0.81	1.62
adipose, donor3	10186-103D6	352.61	24.51	3.54	2.45	1.36	2.45
adipose, donor4	10187-103D7	209.75	20.80	0.00	1.73	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	102.11	16.10	0.32	0.00	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	185.52	18.19	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	122.07	24.95	1.20	0.53	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	120.41	46.45	0.71	0.71	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	388.58	24.81	1.16	1.62	0.46	0.46
amniotic membrane cells, donor2	12236-129G4	273.53	25.70	1.35	0.34	1.01	0.68
amniotic membrane cells, donor3	12237-129G5	252.77	25.34	0.59	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	189.73	73.52	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	205.00	31.23	0.00	1.82	0.20	0.61
amygdala, newborn, donor10223	10360-105E9	298.56	49.06	4.20	0.97	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	240.91	17.83	0.89	0.51	0.13	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	117.37	18.53	0.00	0.66	0.00	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	166.68	36.08	0.00	1.00	1.00	0.00
aorta, adult, pool1	10052-101G7	160.63	24.91	1.57	0.59	0.78	0.39
appendix, adult	10189-103D9	180.09	26.00	0.78	0.00	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	173.34	45.06	0.34	0.69	0.00	0.00
artery, adult	10190-103E1	173.91	29.89	0.00	4.08	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	524.27	45.78	4.35	1.45	0.58	1.30
b cell line:RPMI1788	10427-106D4	109.59	25.58	0.59	0.30	0.30	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	198.93	30.52	0.28	1.94	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	142.10	21.53	0.20	0.69	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	306.47	22.09	3.51	1.51	0.33	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	57.04	13.42	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	192.40	25.53	1.20	0.54	0.33	0.22
blood, adult, pool1	10053-101G8	57.58	15.50	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	170.41	24.83	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	327.97	22.94	8.77	1.35	0.67	2.02
brain, adult, donor1	10084-102B3	201.94	41.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	225.39	35.08	1.22	1.00	0.22	0.22
brain, fetal, pool1	10085-102B4	178.98	53.43	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	190.95	18.50	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	185.36	25.34	0.00	0.50	0.00	0.12
breast, adult, donor1	10080-102A8	114.91	21.47	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	150.67	16.39	0.38	0.51	0.00	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	244.90	31.54	2.16	0.62	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	215.72	94.62	0.69	3.45	0.23	2.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	71.90	11.62	0.97	0.48	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	83.69	12.69	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	255.40	16.19	0.22	0.77	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	124.86	32.96	0.32	0.32	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	95.56	23.96	0.27	1.06	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	214.15	43.75	0.00	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	190.08	30.45	0.33	0.50	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	178.81	39.74	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	333.64	45.41	5.13	1.46	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	302.98	84.48	0.00	0.00	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	422.75	107.82	6.62	3.20	1.92	0.85
cerebellum, adult, pool1	10083-102B2	212.83	64.50	4.14	0.69	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	893.39	54.80	9.96	0.83	0.00	1.66
cerebral meninges, adult	10188-103D8	276.60	36.81	2.02	0.76	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	162.26	17.54	2.92	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	185.19	28.18	1.87	0.58	0.58	0.43
cervical cancer cell line:ME-180	10553-107I4	294.64	17.07	2.32	0.50	0.66	0.33
cervix, adult, pool1	10013-101C4	338.28	34.33	5.25	1.36	2.10	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	367.99	33.02	5.43	0.98	0.70	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	158.06	14.37	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	613.43	28.46	2.24	1.24	0.25	1.62
choriocarcinoma cell line:SCH	10785-110H2	487.30	15.52	0.25	1.23	0.12	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	271.09	9.25	0.00	0.00	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	543.91	15.10	3.99	1.42	0.57	1.42
chorionic membrane cells, donor2	12239-129G7	266.18	32.71	0.60	0.40	0.50	1.29
chorionic membrane cells, donor3	12240-129G8	796.75	15.94	3.85	1.65	2.20	5.49
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	61.60	8.08	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	202.66	16.33	21.32	0.77	3.84	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	75.18	14.99	0.63	0.21	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	62.66	37.24	0.00	0.26	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	59.02	34.10	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	70.25	36.65	0.00	0.61	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	96.58	44.17	0.29	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	124.32	17.72	0.52	0.26	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	136.92	36.12	0.00	2.97	0.00	1.14
clear cell carcinoma cell line:TEN	10636-108I6	137.59	16.14	0.17	1.04	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	138.56	8.42	26.54	0.18	5.86	0.18
colon carcinoma cell line:COLO-320	10420-106C6	259.22	41.43	0.00	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	174.93	28.56	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	212.33	28.79	1.65	0.12	0.35	0.47
colon, fetal, donor1	10070-101I7	176.74	22.25	1.24	0.00	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	504.19	41.25	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	200.29	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	348.44	36.54	6.37	0.85	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	238.92	28.22	3.32	0.45	0.30	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	278.07	29.89	3.24	0.71	0.71	0.56
corpus callosum, adult, pool1	10042-101F6	359.00	43.45	1.11	0.33	0.33	0.88
cruciate ligament, donor2	10295-104G7	238.28	21.88	4.05	0.81	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	158.10	24.08	0.80	0.00	0.80	0.80
diencephalon, adult	10193-103E4	208.55	27.12	1.92	1.20	0.48	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	107.00	25.49	0.23	2.07	0.00	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	219.00	24.62	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	118.19	13.24	0.24	0.00	0.00	0.24
ductus deferens, adult	10196-103E7	156.98	25.42	1.00	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	239.08	30.24	2.88	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	372.97	39.73	0.74	4.41	0.00	2.21
dura mater, adult, donor1	10041-101F5	341.66	28.08	6.44	0.99	1.24	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	140.79	6.88	0.00	0.67	0.00	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	320.69	28.23	0.14	0.86	0.14	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	176.35	32.68	1.23	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	154.38	50.25	0.00	0.30	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	156.84	36.12	0.93	0.31	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	183.89	35.46	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	233.97	18.44	1.01	0.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	219.84	38.97	1.09	1.63	0.72	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	240.42	25.57	0.16	1.93	0.00	1.61
epidermoid carcinoma cell line:A431	10426-106D3	113.72	12.56	0.44	0.11	0.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	178.84	25.85	0.44	0.00	0.22	0.00
epididymis, adult	10197-103E8	201.78	24.07	0.42	1.67	0.63	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	107.16	37.97	0.00	0.53	0.00	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	147.07	23.20	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	108.64	38.00	0.13	0.66	0.00	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	88.28	30.02	0.20	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	108.44	36.52	0.22	0.90	0.00	0.90
esophagus, adult, pool1	10015-101C6	171.48	22.09	0.85	0.42	0.42	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	150.66	27.30	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	234.21	26.56	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	172.54	21.04	4.21	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	261.93	17.86	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	221.27	20.64	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	253.59	16.03	1.46	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	299.74	20.59	3.81	2.54	1.02	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	197.98	23.08	3.59	1.15	0.51	0.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	153.14	37.27	1.42	0.71	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	249.85	48.60	1.50	0.38	0.38	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	187.06	26.42	1.80	0.30	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	223.29	55.32	0.55	0.27	0.09	0.18
gall bladder, adult	10198-103E9	188.56	26.07	0.48	0.00	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	114.89	62.28	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	126.24	49.67	0.75	0.37	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	295.28	18.38	4.22	3.38	1.06	1.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	184.71	36.75	0.19	0.39	0.00	0.58
gastric cancer cell line:AZ521	10549-107H9	258.23	34.92	0.98	0.66	1.48	0.00
gastric cancer cell line:GSS	10560-108A2	374.33	62.24	14.64	0.92	6.41	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	350.68	18.96	0.23	0.46	0.00	1.14
giant cell carcinoma cell line:LU65	10487-107B1	216.06	28.91	8.38	0.80	1.72	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	283.84	54.44	0.28	0.70	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	244.43	22.70	3.49	0.50	1.75	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	113.89	34.09	0.11	0.00	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	93.39	26.82	0.14	0.14	0.00	0.28
glioblastoma cell line:T98G	10485-107A8	141.72	47.79	0.33	0.44	0.00	0.33
glioma cell line:GI-1	10413-106B8	109.83	27.24	0.00	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	193.16	24.05	0.00	0.73	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	248.49	39.30	0.24	0.49	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	346.41	42.45	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	314.95	24.51	0.53	1.60	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	589.76	36.71	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	163.93	21.86	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	104.53	26.13	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	128.64	20.16	0.00	0.64	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	362.70	39.02	3.21	0.92	1.84	0.46
hIPS +CCl2, biol_rep2	14384-156C1	390.04	41.15	3.20	1.37	3.20	0.00
hIPS +CCl2, biol_rep3	14385-156C2	381.30	50.24	4.51	1.93	1.93	0.00
hIPS, biol_rep1	14380-156B6	301.83	63.24	2.87	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	308.64	45.95	4.12	2.06	0.00	2.06
hIPS, biol_rep3	14382-156B8	285.80	34.21	1.10	2.21	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	53.73	15.80	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	208.68	24.52	1.79	0.90	0.30	0.90
heart - pulmonic valve, adult	10206-103F8	185.91	23.27	1.05	0.52	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	338.89	22.48	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	138.96	18.57	0.82	0.41	0.00	0.61
heart, adult, diseased, donor1	10051-101G6	216.75	22.99	1.70	2.13	0.85	0.00
heart, adult, pool1	10016-101C7	175.70	25.99	1.38	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	592.57	32.24	8.21	1.13	2.05	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	131.43	16.04	1.85	0.31	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	514.91	39.24	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	384.53	34.92	6.63	1.88	2.32	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	409.64	35.56	8.37	2.18	2.06	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	405.12	36.99	8.69	1.82	2.43	0.81
hepatoma cell line:Li-7	10484-107A7	115.00	18.02	0.11	0.78	0.11	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	195.98	18.89	4.72	0.60	1.11	0.30
hippocampus - adult, donor10196	10169-103B7	226.17	34.07	0.95	0.95	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	206.75	31.43	0.82	1.43	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	299.27	61.75	1.00	0.50	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	323.22	58.51	2.47	0.35	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	498.04	48.83	4.27	9.16	2.44	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	301.99	27.49	2.55	1.77	1.96	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	360.53	39.61	3.55	3.81	1.78	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	371.59	62.03	0.56	3.38	0.00	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	289.46	46.99	0.26	4.65	0.52	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	433.89	72.13	0.00	3.42	0.38	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	520.85	48.46	1.17	3.80	0.88	6.13
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	440.55	44.16	1.51	2.59	0.00	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	514.25	47.96	1.67	3.34	0.42	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	693.33	47.83	1.66	1.42	0.00	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	539.21	37.77	1.77	3.70	1.45	3.70
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	617.42	54.54	4.04	0.67	0.67	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	236.45	26.76	3.44	2.35	2.66	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	224.52	34.88	7.86	5.90	3.44	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	302.85	54.11	9.60	3.49	3.49	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	356.43	50.21	0.00	2.29	0.19	4.96
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	324.44	58.87	0.44	1.31	0.00	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	340.34	47.98	0.50	1.00	0.50	6.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	263.75	28.64	0.57	2.26	0.57	3.58
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	304.66	30.01	1.82	3.18	0.45	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	318.87	29.76	1.25	0.63	0.00	3.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	498.07	28.74	4.08	2.78	1.80	5.23
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	474.95	29.90	2.61	5.81	0.87	5.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	530.29	26.01	2.69	3.59	0.00	4.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	317.39	29.00	2.22	4.43	1.48	2.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	292.99	29.10	3.42	3.42	2.28	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	438.12	42.46	4.90	4.08	2.04	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	353.14	44.71	0.70	4.22	0.70	4.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	306.92	38.64	0.63	1.90	0.63	5.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	375.25	42.67	0.91	1.82	0.30	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	318.55	26.89	1.03	2.07	0.00	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	357.99	27.23	0.00	0.00	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	426.87	30.01	1.28	1.03	0.00	3.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	419.26	32.72	1.28	4.60	0.51	5.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	561.10	31.80	1.51	4.54	0.76	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	484.59	38.65	2.35	3.02	0.34	3.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	311.78	32.60	4.83	5.31	1.45	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	321.32	41.89	6.24	6.24	0.89	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	351.71	43.90	3.90	2.93	1.46	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	359.71	47.68	0.00	3.36	0.61	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	862.11	113.86	0.00	26.03	0.00	26.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	454.05	63.87	0.66	1.99	0.33	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	518.29	45.97	2.19	3.28	1.09	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	507.72	41.25	2.17	1.81	0.72	3.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	476.16	37.01	0.71	2.49	0.36	5.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	621.75	34.61	0.00	7.16	1.19	7.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	815.94	44.83	3.39	3.79	0.27	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	497.03	35.56	0.54	3.77	1.35	4.31
immature langerhans cells, donor1	11904-125F5	570.50	26.64	20.34	1.21	0.97	0.48
immature langerhans cells, donor2	11905-125F6	186.94	22.18	5.54	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	266.96	53.66	1.32	0.38	0.09	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	98.52	8.78	0.00	0.65	0.00	0.98
kidney, adult, pool1	10017-101C8	205.96	34.04	1.10	0.50	0.20	0.40
kidney, fetal, pool1	10045-101F9	283.23	30.98	1.41	0.42	0.42	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	253.93	26.42	0.71	0.43	0.14	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	153.72	12.72	3.04	0.14	0.00	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	177.99	16.33	1.28	0.00	0.37	0.18
left atrium, adult, donor1	10079-102A7	114.42	16.89	2.72	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	154.22	13.65	2.53	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	140.36	37.76	0.55	0.55	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	105.98	16.88	0.72	1.08	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	94.57	22.28	0.00	0.54	0.00	1.09
leiomyoma cell line:15425	10571-108B4	124.32	22.34	0.49	0.97	0.00	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	171.43	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	81.55	42.87	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	102.24	18.42	1.53	0.24	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	174.49	22.18	1.87	1.72	1.41	0.62
liposarcoma cell line:SW 872	10726-110A6	172.89	27.78	0.24	0.37	0.00	0.12
liver, adult, pool1	10018-101C9	162.87	23.50	0.32	0.16	0.16	0.16
liver, fetal, pool1	10086-102B5	80.90	20.70	0.00	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	210.72	21.14	0.87	0.29	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	213.16	25.47	0.74	0.37	0.00	0.37
locus coeruleus, adult, donor10258	10375-105G6	155.74	20.60	1.13	2.54	0.00	1.41
locus coeruleus, newborn, donor10223	10362-105F2	308.73	30.71	5.05	1.68	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	93.14	11.49	0.83	0.00	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	117.20	46.88	0.69	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	366.05	22.41	2.77	1.85	0.79	0.79
lung, adult, pool1	10019-101D1	204.60	25.52	2.60	0.83	0.35	0.00
lung, fetal, donor1	10068-101I5	534.28	48.52	4.00	0.00	0.57	1.43
lung, right lower lobe, adult, donor1	10075-102A3	169.08	30.24	2.29	2.29	0.00	0.46
lymph node, adult, donor1	10077-102A5	97.99	28.40	0.00	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	56.77	14.25	0.22	0.22	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	124.97	35.17	0.45	0.60	0.00	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	225.12	20.39	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	212.67	28.86	0.44	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	199.23	26.36	0.62	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	197.24	31.53	0.47	0.00	0.24	0.24
mature adipocyte, donor4	12234-129G2	180.04	27.90	0.00	0.00	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	278.05	32.16	3.81	0.48	1.19	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	174.84	37.23	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	190.34	29.24	0.55	0.55	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	191.57	36.85	0.32	1.59	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	234.14	62.27	6.82	0.43	0.43	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	203.85	42.86	1.18	1.01	0.17	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	185.91	30.35	0.21	0.21	0.21	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	169.51	86.68	0.00	3.85	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	114.83	43.06	0.00	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	257.71	66.76	5.03	0.36	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	235.58	27.91	0.65	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	233.60	37.77	1.70	1.39	0.15	0.46
medulla oblongata, adult, pool1	10038-101F2	281.29	30.94	1.88	0.33	0.33	0.00
medulla oblongata, newborn, donor10223	10361-105F1	382.25	33.33	4.17	1.74	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	205.91	28.34	0.00	1.33	0.00	0.66
medulloblastoma cell line:ONS-76	10759-110E3	247.60	21.28	2.81	0.37	0.86	0.12
melanoma cell line:COLO 679	10514-107E1	442.60	16.24	7.47	2.16	3.45	0.86
melanoma cell line:G-361	10465-106H6	988.40	19.00	73.29	4.34	12.76	0.81
meningioma cell line:HKBMM	10691-109F7	170.05	24.60	0.72	1.81	0.00	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	352.46	43.18	2.64	0.88	0.00	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	339.58	43.29	0.00	1.81	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	131.49	33.91	0.77	1.53	0.46	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	106.16	18.00	0.73	0.73	0.00	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	118.43	31.47	0.00	0.41	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	136.68	23.60	1.55	0.70	1.26	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	113.62	20.80	0.77	0.77	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	118.69	37.48	0.00	0.69	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	64.88	14.42	0.00	0.51	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	88.68	23.81	0.23	0.92	0.12	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	125.08	26.00	0.40	1.06	0.53	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	182.17	26.33	1.08	1.08	1.22	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	191.49	34.71	2.56	1.14	0.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	116.92	22.40	0.99	1.32	0.66	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	193.17	30.86	1.94	0.42	0.97	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	147.31	38.05	1.40	0.70	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	129.64	25.93	0.82	0.00	0.61	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	213.16	29.48	3.24	1.08	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	155.07	21.62	1.34	0.31	0.21	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	190.83	19.84	0.23	1.37	0.00	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	307.12	27.27	0.84	2.52	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	183.81	28.84	4.03	1.79	1.20	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	153.27	25.12	0.96	1.23	0.35	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	106.40	32.77	0.74	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	207.18	35.20	1.14	2.58	0.29	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	371.76	61.89	0.84	1.68	0.42	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	109.14	21.92	0.91	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	114.85	23.28	0.51	0.26	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	143.44	24.08	0.26	0.52	0.52	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	115.84	21.87	0.62	0.92	0.00	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	110.15	21.18	0.00	1.88	0.00	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	137.07	26.74	0.34	1.35	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	116.71	26.72	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	129.75	24.56	0.00	2.32	0.00	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	96.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	152.28	25.96	0.87	1.15	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	125.61	24.76	0.45	0.89	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	132.19	25.48	0.00	1.20	0.00	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	136.40	18.33	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	108.08	18.13	0.00	2.35	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	108.08	25.38	0.41	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	144.76	26.63	0.00	1.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	128.52	32.81	0.00	5.47	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	149.78	46.48	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	133.16	31.50	0.32	1.62	0.00	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	144.04	29.10	0.00	1.45	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	137.53	23.99	0.00	0.00	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	134.93	17.99	0.00	0.82	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	120.11	22.93	0.39	1.55	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	113.33	27.28	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	141.07	15.90	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	109.65	42.90	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	128.67	24.90	0.59	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	145.00	31.68	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	270.52	54.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	119.71	29.77	0.63	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	79.67	20.69	0.69	0.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	92.42	21.49	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	75.84	11.98	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	75.77	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	57.86	10.59	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	54.82	11.12	0.00	0.00	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	60.13	14.74	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	57.04	13.40	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	66.83	12.03	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	88.70	20.11	0.00	0.00	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	97.58	15.41	2.57	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	95.00	19.28	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	93.52	14.35	0.00	2.47	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	81.87	12.34	1.12	2.24	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	87.78	13.99	0.00	3.18	0.00	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	112.03	17.33	0.00	0.81	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	119.93	19.63	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	101.36	17.74	0.00	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	55.83	10.32	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	67.78	18.08	0.00	0.00	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	60.95	11.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	85.32	19.84	0.00	0.00	0.20	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	72.36	16.22	0.00	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	81.49	20.37	0.00	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	219.73	30.17	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	106.07	35.44	0.24	0.00	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	178.39	15.29	1.16	0.93	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	132.48	25.64	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	100.90	14.39	0.00	0.62	0.00	0.10
mesothelioma cell line:Mero-25	10850-111F4	113.70	16.11	0.00	0.91	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	116.37	36.43	0.24	0.73	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	125.77	36.31	0.00	0.44	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	146.12	18.92	0.00	2.10	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	202.05	34.73	0.68	0.68	0.17	1.02
mesothelioma cell line:Mero-84	10855-111F9	122.60	16.68	0.25	0.25	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	119.05	21.33	0.21	0.41	0.21	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	153.56	23.19	0.17	0.66	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	198.55	25.34	0.18	0.72	0.00	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	85.58	22.21	0.34	0.85	0.00	0.34
mesothelioma cell line:NCI-H28	10845-111E8	26.21	10.18	0.76	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	153.64	28.38	0.00	0.98	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	106.48	18.42	0.00	1.08	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	120.53	30.90	1.15	0.38	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	186.35	46.04	0.85	0.24	0.37	0.61
migratory langerhans cells, donor3	11903-125F4	188.99	33.20	0.18	0.90	0.00	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	129.29	16.98	0.33	0.98	0.00	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	140.51	51.71	0.85	1.70	0.00	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	119.09	11.52	0.00	0.23	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	89.25	16.17	2.85	0.00	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	89.81	21.25	0.37	0.74	0.00	0.37
myeloma cell line:PCM6	10474-106I6	102.79	7.31	0.79	0.20	0.40	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	176.54	19.28	0.00	1.01	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	75.71	27.26	0.59	0.20	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	141.06	10.47	0.00	0.22	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	149.88	13.68	0.15	0.15	0.00	0.15
nasal epithelial cells, donor2	12227-129F4	278.20	12.14	0.55	1.10	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	205.21	26.46	0.00	0.46	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	154.91	68.29	0.37	0.19	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	104.81	20.67	0.00	0.21	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	329.10	39.32	0.56	0.75	0.00	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	140.67	26.09	0.24	0.24	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	117.84	28.03	0.00	1.27	0.32	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	110.69	13.69	0.20	0.60	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	46.41	10.81	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	128.03	20.76	0.27	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	505.74	44.62	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	292.17	66.40	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	179.94	18.94	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	302.56	47.35	1.86	0.85	1.01	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	75.25	33.62	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	126.00	25.01	0.96	0.64	0.32	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	153.72	25.23	1.05	0.79	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	242.88	40.59	1.22	0.19	0.47	0.09
occipital cortex - adult, donor10196	10172-103C1	175.13	45.33	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	219.25	29.52	0.54	1.07	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	270.41	83.71	3.64	0.73	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	180.27	35.69	1.57	0.52	0.52	1.31
occipital lobe, fetal, donor1	10073-102A1	167.35	57.07	1.29	2.15	0.86	1.29
occipital pole, adult, pool1	10036-101E9	229.27	42.57	1.26	0.32	0.39	0.08
olfactory region, adult	10195-103E6	205.19	37.06	1.15	1.53	0.19	0.57
optic nerve, donor1	10277-104E7	332.17	36.02	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	130.08	22.10	0.91	0.11	0.46	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	211.16	17.86	0.82	0.41	0.14	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	147.65	17.10	0.17	0.68	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	292.35	25.53	2.31	1.39	0.46	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	219.01	26.16	1.47	0.59	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	194.34	33.64	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	499.19	20.99	13.78	0.85	2.33	0.21
ovary, adult, pool1	10020-101D2	380.42	22.62	4.98	0.87	1.22	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	113.66	7.15	0.18	0.37	0.18	0.18
pancreas, adult, donor1	10049-101G4	162.73	13.17	1.88	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	504.84	21.52	4.75	1.40	1.12	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	192.84	50.42	0.68	3.24	0.51	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	138.76	17.39	0.99	0.17	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	218.46	41.18	1.19	0.46	0.00	0.27
parietal cortex, adult, donor10258	10373-105G4	173.96	41.10	0.00	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	193.74	24.45	0.94	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	177.01	30.21	1.43	1.14	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	225.06	35.34	1.23	0.00	0.18	0.18
parietal lobe, fetal, donor1	10072-101I9	212.39	50.43	0.97	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	251.23	64.30	2.24	0.75	1.12	0.00
parotid gland, adult	10199-103F1	183.77	19.73	0.00	0.62	0.00	0.62
penis, adult	10200-103F2	196.05	29.00	0.00	2.69	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	42.58	9.30	0.00	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	113.50	15.74	0.29	0.15	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	192.86	19.35	1.94	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	235.11	33.16	1.18	0.00	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	136.08	23.20	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	266.10	39.46	3.04	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	310.62	56.81	6.78	2.08	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	154.07	45.12	0.00	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	364.00	20.86	0.32	0.97	0.11	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	52.04	12.71	0.26	0.40	0.40	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	151.75	18.99	4.05	0.47	0.78	0.47
pons, adult, pool1	10033-101E6	179.28	24.01	1.55	0.26	0.26	0.34
postcentral gyrus, adult, pool1	10032-101E5	227.18	42.54	0.52	0.17	0.61	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	495.66	20.91	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	159.73	22.03	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	105.62	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	142.75	26.22	0.44	1.02	0.44	0.58
prostate cancer cell line:PC-3	10439-106E7	203.83	44.83	0.18	0.91	0.00	0.18
prostate, adult, pool1	10022-101D4	235.34	25.76	1.18	0.36	0.45	0.54
putamen, adult, donor10196	10176-103C5	198.29	39.66	0.00	0.47	0.00	0.24
putamen, adult, donor10252	10152-102I8	241.17	41.18	0.00	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	203.26	44.81	0.00	4.37	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	180.00	34.31	0.97	0.97	0.00	0.00
putamen, newborn, donor10223	10365-105F5	209.91	38.23	3.00	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	92.23	6.69	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	367.22	37.56	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	93.28	22.47	0.21	0.00	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	28.17	19.47	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	452.27	26.14	7.75	1.19	1.99	0.30
retinoblastoma cell line:Y79	10475-106I7	152.50	34.03	0.00	0.78	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	178.28	15.61	0.61	0.37	0.00	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	251.96	36.56	0.00	0.56	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	176.58	22.74	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	143.40	16.19	1.13	0.49	0.32	0.65
salivary acinar cells, donor2	11772-123I8	197.86	16.66	1.24	1.93	0.00	0.14
salivary acinar cells, donor3	11773-123I9	171.47	11.92	0.00	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	239.08	29.74	1.72	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	139.70	39.80	0.00	0.67	0.08	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	110.03	36.21	0.24	0.12	0.00	0.47
seminal vesicle, adult	10201-103F3	152.90	24.87	2.12	3.17	1.06	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	361.96	50.04	3.89	1.70	0.49	2.67
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	116.51	21.64	0.00	1.01	0.00	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	142.50	30.11	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	71.06	9.13	0.00	0.13	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	2493.39	237.30	10.61	3.98	1.88	2.76
signet ring carcinoma cell line:NUGC-4	10483-107A6	267.60	47.48	1.29	1.29	0.39	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	131.23	13.48	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	110.34	13.55	0.24	0.24	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	183.92	31.16	3.02	1.01	1.01	3.02
skin, adult, donor1	10074-102A2	162.85	27.14	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	277.74	29.67	5.05	0.63	1.26	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	217.79	25.35	0.00	0.00	0.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	448.85	34.67	0.32	3.15	0.32	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	210.87	64.76	0.39	0.96	0.39	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	258.61	30.66	1.65	0.33	0.66	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	108.09	22.52	0.16	0.64	0.32	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	188.28	19.18	0.22	1.09	0.44	0.44
small intestine, adult, pool1	10024-101D6	397.51	40.01	4.42	1.31	0.84	0.72
small intestine, fetal, donor1	10064-101I1	306.63	29.24	2.46	2.95	0.74	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	49.24	21.54	0.51	1.03	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	157.14	27.91	0.52	0.26	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	42.08	21.98	0.00	0.00	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	219.54	21.56	1.38	1.38	0.92	1.38
spinal cord, adult, donor10252	10159-103A6	231.04	40.22	0.79	0.79	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	236.59	37.36	0.69	2.08	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	308.58	29.88	1.22	1.22	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	450.03	40.87	4.13	1.38	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	134.87	17.33	0.15	0.30	0.15	0.15
spleen, adult, pool1	10025-101D7	149.01	30.51	0.55	0.44	0.11	0.00
spleen, fetal, pool1	10044-101F8	211.67	32.26	1.35	0.24	0.40	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	97.30	24.22	0.21	0.31	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	306.27	10.82	0.76	0.38	0.38	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	141.53	20.27	0.00	0.00	0.35	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	163.80	13.29	0.39	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	137.88	15.87	0.34	0.23	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	183.42	16.52	0.00	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	153.15	45.27	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	216.80	32.04	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	175.46	21.08	0.00	0.00	0.00	1.71
substantia nigra - adult, donor10196	10178-103C7	162.82	108.55	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	207.71	24.92	0.42	0.62	0.00	0.62
substantia nigra, adult, donor10258	10371-105G2	301.56	34.66	2.07	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	358.94	29.68	1.41	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	212.30	40.81	0.00	0.46	0.00	0.92
temporal lobe, adult, pool1	10031-101E4	214.81	44.50	0.85	0.08	0.34	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	145.30	34.19	0.00	0.71	0.00	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	182.85	40.44	0.44	0.00	0.00	1.32
tenocyte, donor1	11763-123H8	199.34	37.35	1.05	2.44	0.35	1.75
tenocyte, donor2	11765-123I1	191.52	23.27	0.76	1.53	1.14	1.14
tenocyte, donor3	11768-123I4	120.10	35.58	0.00	2.59	0.00	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	504.78	34.16	11.73	1.02	8.50	1.87
teratocarcinoma cell line:NCR-G1	10798-110I6	545.84	16.03	4.32	3.55	1.23	1.08
teratocarcinoma cell line:PA-1	10807-111A6	324.37	20.61	1.08	1.39	0.77	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	156.91	16.00	0.51	0.76	0.38	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	180.01	26.85	0.00	0.38	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	142.33	15.81	0.00	0.65	0.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	243.95	36.80	0.00	1.95	0.00	0.65
testis, adult, pool1	10026-101D8	191.02	35.76	1.61	0.75	0.32	0.54
testis, adult, pool2	10096-102C6	189.00	49.62	0.45	0.90	0.00	1.35
thalamus - adult, donor10196	10168-103B6	279.31	34.22	3.31	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	225.83	35.01	0.31	1.09	0.16	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	357.19	93.92	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	180.66	22.40	1.98	1.32	1.32	0.16
thalamus, newborn, donor10223	10366-105F6	353.82	33.94	6.90	0.58	1.15	0.00
throat, adult	10209-103G2	182.51	21.47	2.00	0.00	0.00	0.75
throat, fetal, donor1	10061-101H7	296.17	23.16	4.88	0.61	1.22	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	149.05	31.00	0.00	0.20	0.00	0.20
thymus, adult, pool1	10027-101D9	176.46	40.16	0.60	0.50	0.00	0.30
thymus, fetal, pool1	10043-101F7	221.11	35.02	1.87	0.52	0.83	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	174.71	27.66	0.40	1.73	0.00	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	126.28	37.02	0.28	1.12	0.00	0.42
thyroid, adult, pool1	10028-101E1	328.74	23.98	2.80	0.65	0.37	0.65
thyroid, fetal, donor1	10060-101H6	294.25	20.30	3.69	1.05	1.85	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	258.69	27.72	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	171.87	20.70	0.93	3.02	0.47	1.40
tongue, fetal, donor1	10059-101H5	225.03	23.25	1.18	0.00	1.18	0.79
tonsil, adult, pool1	10047-101G2	190.63	34.46	0.80	0.20	0.10	0.60
trachea, adult, pool1	10029-101E2	275.74	31.49	3.11	0.57	0.57	0.00
trachea, fetal, donor1	10058-101H4	332.38	29.62	4.62	1.15	0.77	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	120.45	21.26	0.00	0.00	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	236.98	20.36	1.93	0.20	1.01	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	178.00	52.65	0.16	1.25	0.16	0.63
tridermal teratoma cell line:HGRT	10694-109G1	226.40	24.73	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	167.52	20.06	1.69	0.76	0.59	0.25
umbilical cord, fetal, donor1	10057-101H3	254.55	14.61	6.26	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	462.23	40.61	6.83	0.17	1.19	0.34
uterus, fetal, donor1	10055-101H1	339.92	38.39	3.07	2.05	0.51	0.00
vagina, adult	10204-103F6	213.89	22.62	0.00	1.29	0.00	0.00
vein, adult	10191-103E2	144.01	27.18	1.75	0.44	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	71.83	16.02	0.00	0.27	0.00	0.27